Back

The phenotypic changes of γδ T cells in COVID-19 patients

2020-04-07 allergy and immunology Title + abstract only
View on medRxiv
Show abstract

A novel pneumonia-associated respiratory syndrome named coronavirus disease-2019 (COVID-19), which caused by SARS-CoV-2 and broken in Wuhan, China in the end of 2019. Unfortunately, there is no specific antiviral agent or vaccine available to treat SARS-CoV-2 infections. Also, information regarding the immunological characteristics in COVID-19 patients remains limited. Here we collected the blood samples from 18 healthy donors (HD) and 38 COVID-19 patients to analyze changes in {gamma}{delta} T ...

Predicted journal destinations

1
Frontiers in Immunology
140 training papers
#1 37.8%
2
PLOS ONE
1737 training papers
Top 58% 10.4%
3
Scientific Reports
701 training papers
Top 37% 6.5%
4
Vaccines
131 training papers
Top 2% 4.8%
5
The Journal of Immunology
19 training papers
Top 0.1% 4.5%
6
Journal of Medical Virology
95 training papers
Top 2% 4.5%
7
Nature Communications
483 training papers
Top 34% 2.2%
8
eLife
262 training papers
Top 18% 2.2%
9
Journal of Clinical Investigation
50 training papers
Top 2% 1.8%
10
Cell Reports Medicine
49 training papers
Top 2% 1.8%
11
Science Immunology
15 training papers
Top 0.3% 1.5%
12
Frontiers in Medicine
99 training papers
Top 13% 1.4%
13
eBioMedicine
82 training papers
Top 5% 1.3%
14
JCI Insight
63 training papers
Top 5% 1.3%
15
npj Vaccines
18 training papers
Top 0.5% 1.1%
16
Vaccine
140 training papers
Top 7% 1.1%
17
The Journal of Infectious Diseases
137 training papers
Top 16% 0.8%
18
Clinical Infectious Diseases
219 training papers
Top 24% 0.8%
19
iScience
74 training papers
Top 11% 0.8%
20
mBio
34 training papers
Top 4% 0.5%
21
Biology Methods and Protocols
19 training papers
Top 2% 0.5%
22
Cell
28 training papers
Top 3% 0.5%
23
Annals of the Rheumatic Diseases
23 training papers
Top 1% 0.5%
24
Communications Biology
36 training papers
Top 8% 0.5%
25
BMC Infectious Diseases
110 training papers
Top 29% 0.5%
26
Journal of Allergy and Clinical Immunology
15 training papers
Top 2% 0.5%
27
Cell Reports
25 training papers
Top 3% 0.5%